Subscribe To
MDRX / Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?
MDRX News
By Zacks Investment Research
October 9, 2023
Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity
Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency. more_horizontal
By Zacks Investment Research
October 4, 2023
Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery
Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health. more_horizontal
By Zacks Investment Research
September 29, 2023
Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve. more_horizontal
By Seeking Alpha
September 22, 2023
Veradigm: Some Promise Combined With Uncertainty
Veradigm Inc. is a small-cap firm in the healthcare industry and its stock is trading near its 52-week low. The company was birthed out of Allscripts more_horizontal
By Zacks Investment Research
May 15, 2023
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
Veradigm (MDRX) continues to hold on to investors' interests owing to its strategic alliances. more_horizontal
By Zacks Investment Research
February 3, 2023
Will (MDRX) Beat Estimates Again in Its Next Earnings Report?
(MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its n more_horizontal
By Zacks Investment Research
January 12, 2023
Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?
Veradigm (MDRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the more_horizontal
By Zacks Investment Research
January 10, 2023
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances. more_horizontal